ALAM
REGN icon

Asahi Life Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Asahi Life Asset Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-782
Closed -$440K – 191
2025
Q3 		$440K Sell
782
-63
-7% -$35.6K 0.24% 87
2025
Q2 		$444K Buy
845
+160
+23% +$89.3K 0.26% 88
2025
Q1 		$434K Buy
+685
New +$471K 0.28% 74
2024
Q2 		– Sell
-227
Closed -$218K – 204
2024
Q1 		$218K Buy
+227
New +$216K 0.13% 164
2023
Q3 		– Sell
-560
Closed -$402K – 230
2023
Q2 		$402K Sell
560
-80
-13% -$61.7K 0.13% 82
2023
Q1 		$526K Buy
+640
New +$483K 0.17% 67
2022
Q3 		– Sell
-200
Closed -$118K – 294
2022
Q2 		$118K Sell
200
-630
-76% -$410K 0.03% 231
2022
Q1 		$580K Buy
+830
New +$525K 0.08% 69
2021
Q3 		– Sell
-1,060
Closed -$592K – 289
2021
Q2 		$592K Buy
1,060
+155
+17% +$78.5K 0.08% 62
2021
Q1 		$428K Sell
905
-150
-14% -$73K 0.06% 128
2020
Q4 		$510K Buy
+1,055
New +$569K 0.07% 105
2019
Q4 		– Sell
-1,350
Closed -$374K – 256
2019
Q3 		$374K Buy
+1,350
New +$399K 0.06% 110

Other funds holding REGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Asahi Life Asset Management's REGN Position: Q4 2025 in Review

Asahi Life Asset Management sold out of Regeneron Pharmaceuticals (REGN) in Q4 2025, closing a stake of 782 shares — an estimated $440K sold.

Asahi Life Asset Management first reported a position in REGN in Q3 2019 and held it in 12 quarters. The position peaked at $592K in Q2 2021. 1,387 funds tracked by Wall St. Rank hold REGN as of Q4 2025.

  • Asahi Life Asset Management reported no remaining Regeneron Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • Asahi Life Asset Management sold 782 Regeneron Pharmaceuticals shares in Q4 2025, an estimated $440K.
  • Asahi Life Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2019 and held it in 12 quarters.
  • Asahi Life Asset Management's Regeneron Pharmaceuticals position peaked at $592K in Q2 2021.
  • 1,387 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2025.

Based on Asahi Life Asset Management's 13F filing for Q4 2025, filed 4 Feb 2026.